You will lead the innovative clinical pharmacology and pharmacometrics strategy for a portfolio of rare disease and oncology programs.
Base: $212,900 to $297,000; Bonus/Equity: Annual bonus and equity compensation eligible; Benefits: Comprehensive benefits package included
Must-have
Nice-to-have
Not specified